PD-L1 expression, tumor mutational burden, and microsatellite instability status in 746 pancreas ductal adenocarcinomas.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.757
Abstract: 757Background: Pancreas ductal adenocarcinomas (PDA) has a 5-year survival rate of 6% with a need for new therapeutic options. The approval of pembrolizumab for some gastrointestinal cancers shows ... read more here.
Keywords: tumor mutational; pancreas ductal; expression tumor; burden microsatellite ... See more keywords
Intraductal papillary mucinous neoplasm to pancreas ductal adenocarcinoma sequence and pancreas cancer screening
Sign Up to like & getrecommendations! Published in 2018 at "Endoscopic Ultrasound"
DOI: 10.4103/eus.eus_49_18
Abstract: 314 Address for correspondence Dr. James J. Farrell, Department of Digestive Diseases, Yale Center for Pancreatic Diseases, Yale School of Medicine, LMP 1080, 15 York Street, New Haven, Connecticut 06510‐3221, USA. E‐mail: [email protected] Received: 2018-06-28;… read more here.
Keywords: papillary mucinous; pancreas ductal; neoplasm pancreas; ductal adenocarcinoma ... See more keywords